Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Regenerative Medicine for Tissue Repair

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract titled Regenerative Medicine for Tissue Repair is a subcontract issued by the Defense Health Agency under the Department of Defense to advance research into regenerative therapies aimed at accelerating tissue repair in combat-related injuries. The focus is on innovative approaches such as stem cell applications and biomaterials designed to restore function and reduce recovery time for severe battlefield trauma. The opportunity was posted on August 7, 2026, with a response deadline of October 30, 2026, at 4:00 PM, providing potential applicants a limited window to submit proposals. The North American Industry Classification System code 541715 indicates this effort falls under research and development in the life sciences, specifically in the biomedical field. Performance of the work is expected to be conducted in Frederick, Maryland, aligning with existing military and medical research infrastructure in the region. This subcontract represents a strategic Department of Defense initiative to bridge cutting-edge medical science with urgent battlefield medical needs.

General Info

Defense Health Agency funds regenerative medicine research in Frederick, Maryland, for battlefield tissue repair via stem cells and biomaterials.

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

Frederick, MD, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Research into regenerative therapies (e.g., stem cells, biomaterials) for rapid tissue repair in combat injuries.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
Pathogen-Agnostic Sepsis CountermeasuresThe contract centers on the research and prototype development of pathogen-agnostic countermeasures for sepsis, targeting treatments or diagnostics effective against multiple infectious agents including Pseudomonas aeruginosa and Shigella. This initiative seeks to identify novel therapeutic or diagnostic platforms that function independently of the specific causative pathogen, addressing the critical challenge of sepsis management in heterogeneous infection scenarios. The work is funded under a subcontract arrangement by the Defense Health Agency within the Department of Defense, reflecting a strategic focus on advancing military and civilian medical readiness through innovative biomedical solutions. The project is tied to NAICS code 541715, categorizing it under research and development in the physical, engineering, and life sciences. The opportunity was posted on August 7, 2026, with a response deadline of October 30, 2026, and the performance location is designated as Frederick. While no set-aside provisions or point of contact details are provided, the emphasis on broad-spectrum effectiveness underscores the need for scalable, broadly applicable technologies that can rapidly respond to complex, multi-pathogen sepsis cases. The contract aims to accelerate the transition from concept to prototype, prioritizing solutions with the potential for immediate deployment in clinical and operational settings.
Defense Health Agency

POSTED

about 15 hours ago

DEADLINE

in 3 months
View Details
NAICS: 541715
New
Federal
Synthesis of compounds and intermediates
Solicitation # 75N98026Q00970
The National Institutes of Health, Office of the Director, Office of Acquisitions, is seeking proposals for the synthesis of compounds and intermediates under solicitation number 75N98026Q00970, issued as a combined synopsis and solicitation in accordance with FAR Subpart 12.6. This procurement is conducted under simplified procedures for commercial items, employing full and open competition without solicitation of small business set-asides, and is not anticipated to exceed the simplified acquisition threshold. The contract will be awarded on a firm-fixed-price basis to the offeror whose proposal provides the best value to the government, assessed on technical merit and cost-effectiveness. The requirement falls under NAICS code 541715 for research and development in the physical, engineering, and life sciences, with a small business size standard of 1,000 employees. Proposals must be submitted by the response deadline of August 24, 2026, and the solicitation incorporates all applicable Federal Acquisition Regulation clauses in effect as of August 7, 2026. The work is to be performed in Bethesda, Maryland, with all correspondence directed to the designated point of contact, Johnstons Jaddua C, via email or phone. This solicitation is not a request for a separate written document, as the announcement serves as the complete solicitation package under streamlined commercial procurement rules. Offerors are expected to respond directly through the SAM.gov portal using the provided link.
National Institutes Of Health Olao

POSTED

about 15 hours ago

DEADLINE

in 16 days
View Details
NAICS: 541715
New
Federal
MTEC Solicitation Summary: Fiscal Year 2026 Multi-Topic Request for Project Proposals
Solicitation # MTEC-26-04-MultiTopic
The Medical Technology Enterprise Consortium (MTEC) is soliciting innovative medical prototype solutions through its Fiscal Year 2026 Multi-Topic Request for Project Proposals, targeting critical gaps in military medical readiness across fourteen distinct Focus Areas. These areas span a broad spectrum of battlefield medical challenges, including prevention of infections from high-priority pathogens like Pseudomonas aeruginosa and Shigella, development of pathogen-agnostic sepsis countermeasures, reduction of barriers to mental health help-seeking, optimization of musculoskeletal injury treatment, advancement of non-addictive analgesics, and creation of sensor systems to monitor blast and blunt trauma exposure. Proposals must align strictly with one Focus Area and demonstrate clear military relevance, with solutions intended for use in austere or contested environments, supporting pre-hospital and early care stages (Roles 1 and 2). All submissions must be prototype-scale projects with a minimum Technology or Knowledge Readiness Level of 3, and must not have been previously submitted to MTEC within the last two years. Proposals are submitted via an Enhanced White Paper format as Stage 1 of a two-stage acquisition process, with selected candidates invited to submit detailed cost proposals in Stage 2. Funding is expected to range from $2 to $3.5 million per award over a 2 to 3-year performance period, contingent on available federal appropriations and technical merit. The solicitation encourages teaming among MTEC members to address complex technical requirements, and leverages a new member directory to facilitate collaboration. Proposals must adhere to the definition of a prototype under 10 U.S.C. § 4022 and may include medical devices, drugs, biologics, knowledge products, or novel delivery systems, but explicitly exclude vaccines, burn wound solutions, discovery-stage efforts, and IV-based interventions where specified. The deadline for Enhanced White Paper submissions is October 30, 2026, and successful projects may be eligible for non-competitive follow-on awards based on demonstrated progress and milestone achievement.
Defense Health Agency

POSTED

about 15 hours ago

DEADLINE

in 3 months
View Details
NAICS: 541715
New
Federal
Multi-Domain Force Applications and Traffic Management for Unmanned Aircraft Systems (M-FAT)
Solicitation # FA8750-25-S-7004
The Department of the Air Force, through the Air Force Research Laboratory’s Rome Research Site, is soliciting white papers under Broad Agency Announcement FA8750-25-S-7004 for research and development in Multi-Domain Force Applications and Traffic Management for Unmanned Aircraft Systems, with an open submission window until August 4, 2030. This two-step process invites initial white papers that must be no longer than four pages, double-spaced, and must include a technical summary, task objective, and proposed deliverables; formal proposals are accepted only by invitation after the initial review. The BAA targets advancements in electronic warfare, cyberspace operations, command and control automation, and low-collateral defeat technologies to counter small unmanned aircraft systems, particularly swarms, with emphasis on blurring the lines between cyber and electronic attack, integrating AI and machine learning for automated decision-making, and developing autonomous interceptors with integrated effects. Additional focus areas include enhancing sensor systems for detection and tracking, creating a cyberspace effects library, and advancing unmanned aircraft traffic management systems to safely integrate with existing air traffic infrastructure. Communication resilience is also sought through novel waveforms, networking protocols, and AI-driven spectrum management. Estimated funding totals approximately $499 million, with individual awards typically ranging from $500,000 to $20 million, though awards up to $99 million are possible. Multiple awards are anticipated, and the government may issue FAR-based contracts, grants, cooperative agreements, or Other Transactions, including prototype agreements with potential follow-on production pathways. Submission deadlines are recommended by fiscal year through 2029, with the final deadline set for August 4, 2030. Offerors must be registered in SAM, disclose organizational conflicts of interest, submit required security documentation including senior and key person profiles, and comply with NIST SP 800-171 cybersecurity baselines. Proposals are evaluated primarily on technical merit and mission alignment, with cost as a lesser factor, and must pass pre-award assessments for science and technology protection and financial responsibility under 2 CFR 200.206. All communications regarding technical matters must be directed to designated points of contact, and only contracting officers may commit the government. Submission noncompliance with formatting, content, or procedural instructions may result in rejection or reduced scores.
FA8750 Afrl Rik

POSTED

about 15 hours ago

DEADLINE

in almost 4 years
View Details
NAICS: 541715
New
Federal
Molecular Engineering for Neural ModulationThe contract seeks to design and develop advanced molecular tools, including engineered proteins and synthetic gene circuits, capable of precisely modulating neural plasticity within targeted brain circuits while avoiding unintended effects on surrounding tissue. The work must enable selective control over synaptic strengthening, weakening, or remodeling mechanisms, leveraging cutting-edge bioengineering approaches to achieve high specificity and minimal off-target activity. This effort is part of a broader initiative to enhance neurotechnological capabilities for defense and biomedical applications, requiring innovative solutions that integrate molecular biology with neuroscience. The project falls under NAICS code 541715 for research and development in the physical, engineering, and life sciences and is issued as a subcontract by the Defense Advanced Research Projects Agency under the Department of Defense. Proposals must be submitted by August 14, 2026, with the solicitation posted on August 6, 2026. The performance location is not specified, and no set-aside provisions apply. The contract aims to push the boundaries of precision neural control through molecular innovation, with outcomes expected to support next-generation neurointerfaces, therapeutic interventions, and cognitive enhancement technologies for national security and medical use.
Defense Advanced Research Projects Agcy

POSTED

1 day ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 339112
New
Federal
Battlefield Medical Diagnostics and DevicesThe contract seeks the development of portable, rapid diagnostic tools specifically designed for use in pre-hospital military environments, aiming to enable immediate medical assessment and decision-making on the battlefield. These devices must be rugged, easy to use under extreme conditions, and capable of delivering accurate diagnostic results without reliance on laboratory infrastructure, supporting frontline medics and combat lifesavers in time-critical scenarios. The technology is expected to address gaps in battlefield triage and early detection of trauma, infection, or chemical exposure, with an emphasis on minimal training requirements and compatibility with existing military medical protocols. The contract is classified as a subcontract under NAICS code 339112, indicating a focus on medical and surgical instrument manufacturing, and is managed by the Defense Health Agency within the Department of Defense. The place of performance is centered in Frederick, and interested parties must submit responses by October 30, 2026. While no set-aside provisions are specified, the requirement targets innovative solutions that can be rapidly integrated into field operations, with performance expectations aligned to mission-critical readiness and reliability standards. Technical proposals must demonstrate feasibility, scalability, and the ability to function reliably in austere and high-stress environments.
Surgical and Medical Instrument Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 3 months
View Details
NAICS: 339112
New
Federal
Anesthesia Solutions for Austere EnvironmentsThe contract seeks the development of safe, portable anesthesia delivery systems tailored for use in austere battlefield environments or Role 1 and Role 2 medical settings, where traditional medical infrastructure is limited or unavailable. The focus is on creating reliable, compact, and easy-to-operate anesthesia equipment that ensures patient safety and consistent delivery of anesthetic agents under challenging conditions, including extreme temperatures, power limitations, and high-stress operational scenarios. The solution must prioritize portability, durability, and rapid deployment without compromising clinical efficacy or reducing the need for highly specialized personnel during use. Submitted proposals must align with the NAICS code 339112, indicating a focus on medical equipment and supplies manufacturing, and are expected to meet rigorous military and medical standards for performance and safety. The opportunity is structured as a subcontract, with responses due by October 30, 2026, and performance expected to center around Frederick, Maryland. The Defense Health Agency within the Department of Defense is managing the solicitation with the goal of enhancing medical readiness and sustaining care capabilities in forward-deployed and resource-constrained environments. There is no set-aside designation specified, and while no point of contact is listed, interested parties are directed to the provided SAM.gov link for further details and submission requirements.
Surgical and Medical Instrument Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 3 months
View Details